Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Triage Risk Screening Tool (TRST-U)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03544957
Recruitment Status : Completed
First Posted : June 4, 2018
Last Update Posted : August 28, 2019
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Régional Metz-Thionville

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study tried to describe diagnostic properties of TRST completed by an emergency doctor, for screening process for fragility of elderly subjects admitted at the accident and emergency department.

Condition or disease
Elderly Subject Fragility

Detailed Description:

A constant increase of emergencies admission of elderly subjects is registered. The current problem is the identification and early screening of these patients upon admission at the accident and emergency department for early tracking in geriatric network. This early assessment could allow a shorter waiting time, a better orientation of patients and a decrease in the number of re-hospitalization.

There are many screening process for fragility tests but there seem to be nonspecifically. The advantage of TRST is its simplicity and speed of filling.

In 2015, Duc et al. have found that TRST may be a screening instrument for elderly subject and is going to require geriatric mobile team (GMT) for evaluation. Unfortunately, the threshold may be too sensitive and GMT solicitation is too high.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 199 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Triage Risk Screening Tool (TRST) as Screening Instrument Elderly Subject Fragility at the Accident and Emergency Department
Actual Study Start Date : October 1, 2018
Actual Primary Completion Date : January 1, 2019
Actual Study Completion Date : April 1, 2019
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. TRST-U [ Time Frame: Day 1 ]
    Triage Risk Screening Tool completed by an emergency doctor


Secondary Outcome Measures :
  1. TRST-G [ Time Frame: Day 1 ]
    Triage Risk Screening Tool completed by a geriatrician

  2. SEGA instrument [ Time Frame: Day 1 ]
    Evaluation of TRST versus SEGA instrument (gold standard)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Elderly subject admitted to the emergency department
Criteria

Inclusion Criteria:

  • Patients who are more than 75 years old
  • Admitted to the emergency department for medical or surgical reason
  • Admitted from Monday to Friday (8h30 AM- 6h PM)

Exclusion Criteria:

  • Patient with specific care (vital emergency, urgent surgery)
  • Patient or his support person opposing the use of data
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03544957


Locations
Layout table for location information
France
CHR Metz Thionville
Metz, Moselle, France, 57085
Sponsors and Collaborators
Centre Hospitalier Régional Metz-Thionville
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Centre Hospitalier Régional Metz-Thionville
ClinicalTrials.gov Identifier: NCT03544957    
Other Study ID Numbers: 2018-02Obs-CHRMT
First Posted: June 4, 2018    Key Record Dates
Last Update Posted: August 28, 2019
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Centre Hospitalier Régional Metz-Thionville:
Screening instrument